Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study
Endocrinology, Diabetes & Metabolism · 2023
DOI: 10.1002/edm2.406 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2023. Verfasst von Rosario Le Moli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Nesima Hospital, Catania, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Hypothyroidism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Therapy for hypothyroid obese patients is still under definition since the thyrotropin‐stimulating hormone (TSH) level is a less reliable marker of euthyroidism than nonobese patients. Indeed, TSH levels positively correlate with body mass index (BMI), and this increase may be a compensatory mechanism aimed at increasing energy expenditure in obese people. In contrast, the correlation of BMI with thyroid hormone levels is not completely clear, and conflicting results have been obtained by several studies. The L‐T4 replacement dose is more variable in obese hypothyroid patients than in nonobese patients, and a recent study indicated that the L‐T4 replacement dose is related to lean body mass in obese thyroidectomized patients. We aimed to study the correlations of L‐T4‐administered dose, thyroid hormone levels and TSH secretion with basal metabolic rate (BMR) and total calculated deiodinase activity (GD) in obese and nonobese athyreotic patients. We also looked for individualized L‐T4 replacement dose set points to be used in clinical practice.
Methods
We studied retrospectively 160 athyreotic patients, 120 nonobese and 40 obese. GD was calculated by SPINA Thyr 4.2, the responsiveness of the hypothalamic/pituitary thyrotrope by Jostel's thyrotropin (TSH) index and BMR by the Mifflin‐St. Jeor formula, the interplay of GD and BMR with L‐T4, thyroid hormones and TSH index (TSHI) was also evaluated.
Results
In our study, the L‐T4 dose was an independent predictor of GD, and approximately 30% of athyreotic patients under L‐T4 therapy had a reduced GD; FT4 levels were higher and negatively modulated by BMR in obese athyreotic patients respect to nonobese, in these patients a T4 to T3 shunt, in terms of TSHI suppression is observed suggesting a defective hypothalamic pituitary T4 to T3 conversion and a resistance to L‐T4 replacement therapy.
Conclusions
L‐t4 dose is the most important predictor of GD, BMR modulates T4 levels in obese athyreotic patients that are resistant to L‐T4 replacement therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi Nesima Hospital, Catania, Italy.
ORCID-Profile: Rosario Le Moli, Marco Russo, Dario Tumino
Zitieren
APA
Le Moli, R., Malandrino, P., Russo, M., Tumino, D., Piticchio, T., Naselli, A., Rapicavoli, V., Belfiore, A., & Frasca, F. (2023). Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.406
Vancouver
Le Moli R, Malandrino P, Russo M, Tumino D, Piticchio T, Naselli A, et al. Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study. Endocrinology, Diabetes & Metabolism. 2023. doi:10.1002/edm2.406
BibTeX
@article{LeMoli2023,
author = {Le Moli, Rosario and Malandrino, Pasqualino and Russo, Marco and Tumino, Dario and Piticchio, Tommaso and Naselli, Adriano and Rapicavoli, Valentina and Belfiore, Antonino and Frasca, Francesco},
title = {Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2023},
doi = {10.1002/edm2.406}
}
EUVIMED